Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020111271 - COMPOSITION FOR TREATING OR PREVENTING SKIN PIGMENTATION

Publication Number WO/2020/111271
Publication Date 04.06.2020
International Application No. PCT/JP2019/046903
International Filing Date 29.11.2019
IPC
A61P 43/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
A61P 17/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61K 35/33 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
33Fibroblasts
C12N 5/07 2010.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
CPC
A61K 35/33
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
33Fibroblasts
A61P 17/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • 株式会社 資生堂 SHISEIDO COMPANY, LTD. [JP]/[JP]
Inventors
  • 小出 さやか KOIDE, Sayaka
  • ▲高▼木 雅哉 TAKAGI, Masaya
  • 山田 章子 YAMADA, Akiko
  • 出田 立郎 IDETA, Ritsuro
  • 佐藤 敬 SATOH, Takashi
Agents
  • 青木 篤 AOKI, Atsushi
  • 三橋 真二 MITSUHASHI, Shinji
  • 渡辺 陽一 WATANABE, Yoichi
  • 中島 勝 NAKAJIMA, Masaru
  • 武居 良太郎 TAKEI, Ryotaro
  • 柴田 潤二 SHIBATA, Junji
Priority Data
2018-22603230.11.2018JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) COMPOSITION FOR TREATING OR PREVENTING SKIN PIGMENTATION
(FR) COMPOSITION POUR LE TRAITEMENT OU LA PRÉVENTION DE LA PIGMENTATION DE LA PEAU
(JA) 皮膚の色素沈着を治療または予防するための組成物
Abstract
(EN)
The present invention provides a composition for treating or preventing skin pigmentation, which contains fibroblasts as an active ingredient, wherein the fibroblasts are those fibroblasts which are less damaged than fibroblasts localized in a site where the skin pigmentation occurs, and the composition is characterized by being intended to be applied to a site where the pigmentation occurs or a dermis tissue around the site.
(FR)
La présente invention concerne une composition pour le traitement ou la prévention de la pigmentation de la peau, qui contient des fibroblastes utilisés comme principe actif, les fibroblastes étant des fibroblastes qui sont moins endommagés que les fibroblastes localisés dans un site où se produit la pigmentation de la peau, et la composition étant caractérisée en ce qu'elle est destinée à être appliquée sur un site où se produit la pigmentation ou un tissu dermique autour du site.
(JA)
本発明は、有効成分として、線維芽細胞を含む、皮膚の色素沈着を治療または予防するための組成物であって、ここで前記線維芽細胞が、前記皮膚の色素沈着部位に局在する線維芽細胞よりも損傷が少ない線維芽細胞であり、前記組成物は、前記色素沈着部位またはその近傍の真皮組織に適用されることを特徴とする、組成物を提供する。
Latest bibliographic data on file with the International Bureau